Clinical Trial: Targeting Pediatric Brain Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Pediatric Brain Tumor
Study Type: INTERVENTIONAL
Official Title: Targeting Pediatric Brain Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
Brief Summary:
This is a longitudinal, dose-finding, open label safety and tolerability phase Ib treatment study.The study hypothesis is that dapagliflozin will be well-tolerated by brain tumor patients on chemotherapy as assessed by tolerability and side effect profiles.
Read more